Cited by Lee Sonogan
The human brain is one of the most mystifying biological structures in nature. Overwhelming research, technology, and innovations in neuroscience have augmented clinical assessments, diagnosis, and treatment capabilities. Nonetheless, there is still much to be discovered about nervous system disorders and defects. Neuralink, a neurotechnology company, is advancing the field of neuroscience and neuroengineering. The company’s initial aim is to develop an implantable brain-machine interface device that will enhance the lives of people with severe brain and spinal cord injuries. Here, we provide insight into Neuralink’s design, early testing, and future applications in neurosurgery. While early testing with small and large animals show promising results, no clinical trials have been conducted to date. Additionally, a term search for “Neuralink” was performed in PubMed. The literature search yielded only 28 references, of which most indirectly mentioned the device but not in direct testing. In order to conclude the safety and viability of the Neuralink device, further research studies are needed to move forward beyond speculation.
Publication: Curus (Peer-Reviewed Journal)
Pub Date: Mar 13, 2021 Doi: 10.7759/cureus.14192
Keywords: brain-machine interface, neuroprosthetics, neuronal amplification, artificial intelligence, neuralink, neuroengineering
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083990/ (Plenty more sections and references in this rearch article)